Journal of the Pancreas is one of the most accessed indexed journals in pancreatic cancer. Journal of the Pancreas(JOP) is indexed / abstracted in Index Medicus, MEDLINE, PubMed, EBSCO, EMBASE, Scopus, and in DOAJ.
Pancreatic cancer is a malignant neoplasm originating from transformed cells arising in tissues forming the pancreas. Pancreatic cancer (cancer of the pancreas) mainly occurs in people aged over 60. If it is diagnosed at an early stage, then an operation to remove the cancer gives some chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. Both the exocrine and endocrine cells of the pancreas can form tumors. But tumors formed by the exocrine cells are much more common. When someone says that they have pancreatic cancer, they usually mean an exocrine pancreatic cancer. Not all of the tumors in the pancreas are cancer. A small number are not cancer (they are benign). Pancreatic cancer cells do not experience programmatic death, but instead continue to grow and divide.
Journal of the Pancreas has been Acquired and published by OMICS Group. OMICS Group started its ride towards knowledge dissemination and research findings on a variety of pure and applied sciences and drawn momentum with 700+ peer-reviewed journals. OMICS Group publishes journals and organizes conferences in the fields of Clinical, Medical, Pharmaceutical, OMICS, Engineering and Life Sciences with the help of 50,000+ editorial board members, serving the requirements of 3.5 readers. OMICS Group has signed an agreement with 150 and more scientific associations across the globe, with a vision to team up and make healthcare and scientific information open access.
Last date updated on June, 2014